Joseph Romano
Fondateur chez Lucid Psycheceuticals, Inc.
Profil
Joseph L.
Romano is the founder of Lucid Psycheceuticals, Inc. and Romano Law.
Prior to this, he served as an Independent Director at FSD Pharma, Inc. He completed his undergraduate degree at Osgoode Hall Law School.
Postes actifs de Joseph Romano
| Sociétés | Poste | Début |
|---|---|---|
Lucid Psycheceuticals, Inc.
 Lucid Psycheceuticals, Inc. Medical/Nursing ServicesHealth Services Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation. | Fondateur | - |
| Romano Law | Fondateur | - |
Anciens postes connus de Joseph Romano
| Sociétés | Poste | Fin |
|---|---|---|
| FSD PHARMA INC. | Directeur/Membre du Conseil | - |
Formation de Joseph Romano
| Osgoode Hall Law School | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FSD PHARMA INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Lucid Psycheceuticals, Inc.
Lucid Psycheceuticals, Inc. Medical/Nursing ServicesHealth Services Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation. | Health Services |
| Romano Law |